Innovative MedTech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Innovative MedTech generated cash of -$183,131, which is less than the previous year. Cash used in financing activities reached the amount of $189,704 last year. Net change in cash is therefore -$44,100.
Cash Flow
| 2012 | -53.43K | 0 | 53.43K |
|---|---|---|---|
| 2013 | 108.66K | 0 | 0 |
| 2014 | -4.39K | 0 | 5K |
| 2019 | -527 | 0 | 443 |
| 2020 | -49.24K | 0 | 50K |
| 2021 | 28.1K | -1.56M | 1.96M |
| 2022 | -582.87K | -10.19K | 460.97K |
| 2023 | -168.97K | 5.40K | 19.82K |
| 2024 | -183.13K | -50.67K | 189.70K |
IMTH Cash Flow Statement (2013 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 157.58K | 301.33K | 433.43K | 766 | 9 | 608 | 0 | 0 | 0 |
Operating activities | |||||||||
Net income | -7.93M | -3.64M | -18.05M | -3.26M | -489.69K | -357.62K | -365.34K | -566.85K | -1.48M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 61.65K | 56.44K | 68.96K | 9.63K | 0 | 0 | 81.19K | 159.65K | 2.54K |
Stock-based compensation expense | 1.72M | 0 | 16.70M | 0 | 50K | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 1.72M | 0 | 16.70M | 0 | 50K | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 63.64K | -38.35K | -7.73K | -93.88K | 0 | 0 | 0 | 0 | 4.90K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.38K |
Accounts payable | 230.17K | 3.32M | 818.53K | 530.95K | 279.12K | 210.15K | 292.29K | 284.28K | 539.62K |
Cash generated by operating activities | -183.13K | -168.97K | -582.87K | 28.1K | -49.24K | -527 | -4.39K | 108.66K | -53.43K |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -50.67K | -12.59K | -46.36K | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | -1.58M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -50.67K | 5.40K | -10.19K | -1.56M | 0 | 0 | 0 | 0 | 0 |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 1.60M | 0 | 0 | 0 | 0 | 1.05M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 189.70K | -92.75K | 300.91K | -208.59K | -50K | 0 | -5K | 0 | 0 |
Cash used in financing activities | 189.70K | 19.82K | 460.97K | 1.96M | 50K | 443 | 5K | 0 | 53.43K |
Net Change In Cash | -44.1K | -143.74K | -132.09K | 432.66K | 757 | -599 | 608 | 108.66K | 0 |
Cash at end of period | 113.48K | 157.58K | 301.33K | 433.43K | 766 | 9 | 608 | 108.66K | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |